STATERA BIOPHARMA INC's ticker is and the CUSIP is 857561104. A total of 32 filers reported holding STATERA BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10 | -99.9% | 130,774 | 0.0% | 0.00% | – |
| Q3 2022 | $16,000 | -56.8% | 130,774 | 0.0% | 0.00% | – |
| Q2 2022 | $37,000 | -9.8% | 130,774 | 0.0% | 0.00% | – |
| Q1 2022 | $41,000 | -86.3% | 130,774 | 0.0% | 0.00% | – |
| Q4 2021 | $300,000 | +67.6% | 130,774 | +68.3% | 0.00% | – |
| Q3 2021 | $179,000 | – | 77,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bell & Brown Wealth Advisors, LLC | 18,313 | $5,000 | 0.00% |
| United Capital Management of KS, Inc. | 15,000 | $4,000 | 0.00% |
| Renaissance Technologies | 1,636,235 | $466,000 | 0.00% |
| Sandhill Capital Partners LLC | 13,570 | $4,000 | 0.00% |
| VANGUARD GROUP INC | 389,110 | $111,000 | 0.00% |
| JANE STREET GROUP, LLC | 35,422 | $10,000 | 0.00% |
| UBS Group AG | 8,553 | $2,000 | 0.00% |
| DOWLING & YAHNKE LLC | 28,875 | $8,000 | 0.00% |
| IFP Advisors, Inc | 500 | $2,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 41,076 | $12,000 | 0.00% |